(Q43537382)

24 November 2017

title

Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction (English)

1 reference

24 November 2017

1 reference

S Yokota

1

1 reference

24 November 2017

T Shirasaka

2

1 reference

24 November 2017

H Nishikawa

3

1 reference

24 November 2017

S Hosoe

4

1 reference

24 November 2017

T Ikeda

5

1 reference

24 November 2017

K Komuta

6

1 reference

24 November 2017

I Kawase

7

1 reference

24 November 2017

T Masuno

8

1 reference

24 November 2017

T Ogura

9

1 reference

24 November 2017

S Kishimoto

10

1 reference

24 November 2017

publication date

1 January 1988

1 reference

Cancer Immunology, Immunotherapy

24 November 2017

published in

1 reference

24 November 2017

volume

26

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

11-17

1 reference

Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2

24 November 2017

cites work

1 reference

12 December 2020

Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes

1 reference

12 December 2020

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

12 December 2020

[Immunotherapy for acute myelogenous leukemia with Nocardia rubra cell-wall skeleton. A randomized controlled study]

1 reference

12 December 2020

Effect of interleukin 2 on cytotoxic effectors: I. Short-term culture of the cytotoxic effectors and the in vivo anti-tumor activity of the cultured effectors isolated from tumor site

1 reference

12 December 2020

Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma

1 reference

12 December 2020

In vivo activation of murine natural killer cell functions by human recombinant DNA interleukin 2

1 reference

12 December 2020

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

12 December 2020

Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer

1 reference

12 December 2020

Killing of tumor cells in vitro by macrophages from mice given injections of squalene-treated cell wall skeleton of Nocardia rubra

1 reference

12 December 2020

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types

1 reference

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

12 December 2020

Lymphokine-induced cytotoxicity: characterization of effectors, precursors, and regulatory ancillary cells

1 reference

12 December 2020

Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer

1 reference

12 December 2020

Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial.

1 reference

12 December 2020

Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.

1 reference

12 December 2020

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

1 reference

12 December 2020

Effect of Nocardia rubra cell wall skeleton on murine interferon production in vitro

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199841

1 reference

Dimensions Publication ID

24 November 2017

1007202202

0 references

1 reference